Exploring the tumor suppressor role of RIN1 in familial thyroid carcinoma

in Endocrine-Related Cancer
Authors:
Luna Picello Department of Biology, University of Padova, Padova, Italy

Search for other papers by Luna Picello in
Current site
Google Scholar
PubMed
Close
,
Mattia Dalle Nogare Department of Biology, University of Padova, Padova, Italy

Search for other papers by Mattia Dalle Nogare in
Current site
Google Scholar
PubMed
Close
,
Daniele Puggina Department of Biology, University of Padova, Padova, Italy

Search for other papers by Daniele Puggina in
Current site
Google Scholar
PubMed
Close
,
Cecilia Salvoro Department of Biology, University of Padova, Padova, Italy

Search for other papers by Cecilia Salvoro in
Current site
Google Scholar
PubMed
Close
,
Gianmaria Pennelli Surgical Pathology Unit, Department of Medicine (DIMED), University of Padova, Padova, Italy

Search for other papers by Gianmaria Pennelli in
Current site
Google Scholar
PubMed
Close
,
Germano Gaudenzi Laboratory of Geriatric and Oncologic Neuroendocrinology Research, IRCCS, Istituto Auxologico Italiano, Milan, Italy

Search for other papers by Germano Gaudenzi in
Current site
Google Scholar
PubMed
Close
,
Silvia Carra Laboratory of Endocrine and Metabolic Research, IRCCS, Istituto Auxologico Italiano, Milan, Italy

Search for other papers by Silvia Carra in
Current site
Google Scholar
PubMed
Close
,
Monica Oldani Laboratory of Geriatric and Oncologic Neuroendocrinology Research, IRCCS, Istituto Auxologico Italiano, Milan, Italy

Search for other papers by Monica Oldani in
Current site
Google Scholar
PubMed
Close
,
Davide Gentilini Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy
Bioinformatics and Statistical Genomics Unit, IRCCS Istituto Auxologico Italiano, Milan, Italy

Search for other papers by Davide Gentilini in
Current site
Google Scholar
PubMed
Close
,
Laura Fugazzola Department of Endocrine and Metabolic Diseases, Istituto Auxologico Italiano IRCCS, Milan, Italy
Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy

Search for other papers by Laura Fugazzola in
Current site
Google Scholar
PubMed
Close
https://orcid.org/0000-0003-0716-481X
,
Antongiulio Faggiano Endocrinology Unit, Department of Clinical and Molecular Medicine, European Neuroendocrine Tumor Society (ENETS) Center of Excellence, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy

Search for other papers by Antongiulio Faggiano in
Current site
Google Scholar
PubMed
Close
,
Giovanni Vitale Laboratory of Geriatric and Oncologic Neuroendocrinology Research, IRCCS, Istituto Auxologico Italiano, Milan, Italy
Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy

Search for other papers by Giovanni Vitale in
Current site
Google Scholar
PubMed
Close
https://orcid.org/0000-0003-2478-683X
,
Gianluca Occhi Department of Biology, University of Padova, Padova, Italy

Search for other papers by Gianluca Occhi in
Current site
Google Scholar
PubMed
Close
https://orcid.org/0000-0003-4065-4677
, and
Giovanni Vazza Department of Biology, University of Padova, Padova, Italy

Search for other papers by Giovanni Vazza in
Current site
Google Scholar
PubMed
Close

Correspondence should be addressed to G Occhi: gianluca.occhi@unipd.it or to G Vazza: giovanni.vazza@unipd.it

(G Occhi and G Vazza contributed equally as senior authors)

Restricted access
Rent on DeepDyve

Sign up for journal news

The genetic component is thought to play an important role in the development of familial non-medullary thyroid carcinoma (fNMTC), but the involved molecular mechanisms and genes are poorly understood. The MAPK kinase cascade, particularly involving RAS and BRAF, is crucial in cancer development, with RIN1 emerging as a notable gene due to its differential expression across various tumor types. We identified a frameshift mutation (c.798delC: p.V267Sfs*83) in the RIN1 gene in a family with non-medullary thyroid cancer (NMTC) through whole-exome sequencing. Paraffin-embedded tumor tissues were analyzed to investigate the mutation’s characteristics and its potential implications within the thyroid cellular context. Functional assays and RNA sequencing using CRISPR/Cas9-edited Nthy-ori 3-1 thyroid cell line and xenograft zebrafish models confirmed the mutation effect and the putative RIN1 tumor suppressor role. The study revealed significant alterations in cellular behavior upon RIN1 knockout, including increased cell viability, proliferation and colony formation, alongside morphological changes indicative of epithelial–mesenchymal transition. Enhanced phosphorylation of ERK and AKT suggested MAPK pathway dysregulation following RIN1 depletion, supporting its potential tumor suppressive role. Phenotypic rescue experiments confirmed that reintroduction of wild-type RIN1 restored normal cellular behavior. RNA sequencing demonstrated differential gene expression between RIN1−/− and control cells, particularly affecting pathways associated with cancer progression, closely resembled signatures specific to NMTC. This study provides compelling evidence supporting RIN1 as a tumor suppressor gene within thyroid cells. In addition, the findings highlight its potential significance as novel gene involved in FNMTC pathogenesis.

Supplementary Materials

 

  • Collapse
  • Expand
  • Abdullah MI , Junit SM , Ng KL , et al. 2019 Papillary thyroid cancer: genetic alterations and molecular biomarker investigations. Int J Med Sci 16 450460. (https://doi.org/10.7150/IJMS.29935)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Adeniran AJ , Zhu Z , Gandhi M , et al. 2006 Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of thyroid papillary carcinomas. Am J Surg Pathol 30 216222. (https://doi.org/10.1097/01.PAS.0000176432.73455.1B)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Ammar SA , Alobuia WM & Kebebew E 2020 An update on familial nonmedullary thyroid cancer. Endocrine 68 502507. (https://doi.org/10.1007/S12020-020-02250-3)

  • Bahar ME , Kim HJ & Kim DR 2023 Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies. Signal Transduct Targeted Ther 8 455. (https://doi.org/10.1038/S41392-023-01705-Z)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Balaji K , Mooser C , Janson CM , et al. 2012 RIN1 orchestrates the activation of RAB5 GTPases and ABL tyrosine kinases to determine the fate of EGFR. J Cell Sci 125 58875896. (https://doi.org/10.1242/JCS.113688)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Basolo F , Pollina L , Fontanini G , et al. 1997 Apoptosis and proliferation in thyroid carcinoma: correlation with bcl-2 and p53 protein expression. Br J Cancer 75 537541. (https://doi.org/10.1038/BJC.1997.93)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Bliss JM , Venkatesh B & Colicelli J 2006 The RIN family of Ras effectors. Methods Enzymol 407 335344. (https://doi.org/10.1016/S0076-6879(05)07028-X)

  • Brock P , Sevigny M , Liyanarachchi S , et al. 2024 PDPR gene variants predisposing to papillary thyroid cancer. Thyroid 34 575582. (https://doi.org/10.1089/THY.2023.0560)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Capezzone M , Robenshtok E , Cantara S , et al. 2021 Familial non-medullary thyroid cancer: a critical review. J Endocrinol Investig 44 943950. (https://doi.org/10.1007/S40618-020-01435-X)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Diquigiovanni C & Bonora E 2021 Genetics of familial non-medullary thyroid carcinoma (FNMTC). Cancers 13 2178. (https://doi.org/10.3390/CANCERS13092178)

  • Fang P , Zhao Z , Tian H , et al. 2012 RIN1 exhibits oncogenic property to suppress apoptosis and its aberrant accumulation associates with poor prognosis in melanoma. Tumour Biol 33 15111518. (https://doi.org/10.1007/S13277-012-0402-7)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Feng ZH , Fang Y , Zhao LY , et al. 2017 RIN1 promotes renal cell carcinoma malignancy by activating EGFR signaling through Rab25. Cancer Sci 108 16201627. (https://doi.org/10.1111/CAS.13297)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Frattini M , Ferrario C , Bressan P , et al. 2004 Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer. Oncogene 23 74367440. (https://doi.org/10.1038/SJ.ONC.1207980)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Gara SK , Jia L , Merino MJ , et al. 2015 Germline HABP2 mutation causing familial nonmedullary thyroid cancer. N Engl J Med 373 448455. (https://doi.org/10.1056/nejmoa1502449)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Gaudenzi G , Albertelli M , Dicitore A , et al. 2017 Patient-derived xenograft in zebrafish embryos: a new platform for translational research in neuroendocrine tumors. Endocrine 57 214219. (https://doi.org/10.1007/s12020-016-1048-9)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Gupta A , Jain S , Khurana N , et al. 2016 Expression of p63 and Bcl-2 in malignant thyroid tumors and their correlation with other diagnostic immunocytochemical markers. J Clin Diagn Res 10 EC04EC08. (https://doi.org/10.7860/JCDR/2016/13899.8157)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • He H , Wu G , Liu H , et al. 2013a Low RIN1 expression in HCC is associated with tumor invasion and unfavorable prognosis. Am J Clin Pathol 140 7381. (https://doi.org/10.1309/AJCPEGWYDD86WWJK)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • He H , Bronisz A , Liyanarachchi S , et al. 2013b SRGAP1 is a candidate gene for papillary thyroid carcinoma susceptibility. J Clin Endocrinol Metab 98 E973E980. (https://doi.org/10.1210/jc.2012-3823)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Hu H , Bliss JM , Wang Y , et al. 2005 RIN1 is an ABL tyrosine kinase activator and a regulator of epithelial-cell adhesion and migration. Curr Biol 15 815823. (https://doi.org/10.1016/J.CUB.2005.03.049)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Jiwang L , Zhendong L , Shuchun L , et al. 2015 Clinicopathologic characteristics of familial versus sporadic papillary thyroid carcinoma. Acta Otorhinolaryngol Ital 35 234.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Kamani T , Charkhchi P , Zahedi A , et al. 2022 Genetic susceptibility to hereditary non-medullary thyroid cancer. Hered Cancer Clin Pract 20 9. (https://doi.org/10.1186/S13053-022-00215-3)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Kempers L , Wakayama Y , van der Bijl I , et al. 2021 The endosomal RIN2/Rab5C machinery prevents VEGFR2 degradation to control gene expression and tip cell identity during angiogenesis. Angiogenesis 24 695714. (https://doi.org/10.1007/s10456-021-09788-4)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Kim BA , Jee HG , Yi JW , et al. 2017 Expression profiling of a human thyroid cell line stably expressing the BRAFV600E mutation. Cancer Genomics Proteomics 14 5368. (https://doi.org/10.21873/cgp.20018)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Kong C , Su X , Chen PI , et al. 2007 Rin1 interacts with signal-transducing adaptor molecule (STAM) and mediates epidermal growth factor receptor trafficking and degradation. J Biol Chem 282 1529415301. (https://doi.org/10.1074/JBC.M611538200)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Lawson ND & Weinstein BM 2002 In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev Biol 248 307318. (https://doi.org/10.1006/dbio.2002.0711)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Lee YM , Yoon JH , Yi O , et al. 2014 Familial history of non-medullary thyroid cancer is an independent prognostic factor for tumor recurrence in younger patients with conventional papillary thyroid carcinoma. J Surg Oncol 109 168173. (https://doi.org/10.1002/JSO.23447)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Lupoli G , Vitale G , Caraglia M , et al. 1999 Familial papillary thyroid microcarcinoma: a new clinical entity. Lancet 353 637639. (https://doi.org/10.1016/S0140-6736(98)08004-0)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Marques IJ , Gomes I , Pojo M , et al. 2021 Identification of SPRY4 as a novel candidate susceptibility gene for familial nonmedullary thyroid cancer. Thyroid 31 13661375. (https://doi.org/10.1089/thy.2020.0290)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Masoodi T , Siraj AK , Siraj S , et al. 2019 Evolution and impact of subclonal mutations in papillary thyroid cancer. Am J Hum Genet 105 959973. (https://doi.org/10.1016/j.ajhg.2019.09.026)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Milstein M , Mooser CK , Hu H , et al. 2007 RIN1 is a breast tumor suppressor gene. Cancer Res 67 1151011516. (https://doi.org/10.1158/0008-5472.CAN-07-1147)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Moses W , Weng J & Kebebew E 2011 Prevalence, clinicopathologic features, and somatic genetic mutation profile in familial versus sporadic nonmedullary thyroid cancer. Thyroid 21 367371. (https://doi.org/10.1089/THY.2010.0256)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Musholt TJ , Musholt PB , Petrich T , et al. 2000 Familial papillary thyroid carcinoma: genetics, criteria for diagnosis, clinical features, and surgical treatment. World J Surg 24 14091417. (https://doi.org/10.1007/S002680010233)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Muzza M , Pogliaghi G , Persani L , et al. 2021 Combined mutational and clonality analyses support the existence of intra-tumor heterogeneity in papillary thyroid cancer. J Clin Med 10 2645. (https://doi.org/10.3390/jcm10122645)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Nauth T , Bazgir F , Voß H , et al. 2023 Cutaneous manifestations in Costello syndrome: HRAS p.Gly12Ser affects RIN1-mediated integrin trafficking in immortalized epidermal keratinocytes. Hum Mol Genet 32 304318. (https://doi.org/10.1093/hmg/ddac188)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Nosé V 2011 Familial thyroid cancer: a review. Mod Pathol 24 (Supplement 2) S19S33. (https://doi.org/10.1038/MODPATHOL.2010.147)

  • Park YJ , Ahn HY , Choi HS , et al. 2012 The long-term outcomes of the second generation of familial nonmedullary thyroid carcinoma are more aggressive than sporadic cases. Thyroid 22 356362. (https://doi.org/10.1089/THY.2011.0163)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Piek MW , de Boer JP , van Duijnhoven F , et al. 2022 The co-occurrence of both breast- and differentiated thyroid cancer: incidence, association and clinical implications for daily practice. BMC Cancer 22 1018. (https://doi.org/10.1186/s12885-022-10069-6)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Rivera M , Ricarte-Filho J , Knauf J , et al. 2010 Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns. Mod Pathol 23 11911200. (https://doi.org/10.1038/MODPATHOL.2010.112)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Sarquis M , Moraes DC , Bastos-Rodrigues L , et al. 2020 Germline mutations in familial papillary thyroid cancer. Endocr Pathol 31 1420. (https://doi.org/10.1007/S12022-020-09607-4)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Tall GG , Barbieri MA , Stahl PD , et al. 2001 Ras-activated endocytosis is mediated by the Rab5 guanine nucleotide exchange activity of RIN1. Dev Cell 1 7382. (https://doi.org/10.1016/S1534-5807(01)00008-9)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Tomshine JC , Severson SR , Wigle DA , et al. 2009 Cell proliferation and epidermal growth factor signaling in non-small cell lung adenocarcinoma cell lines are dependent on Rin1. J Biol Chem 284 2633126339. (https://doi.org/10.1074/jbc.M109.033514)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Vitale G , Gaudenzi G , Dicitore A , et al. 2014 Zebrafish as an innovative model for neuroendocrine tumors. Endocr Relat Cancer 21 R67R83. (https://doi.org/10.1530/ERC-13-0388)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Wang Y , Waldron RT , Dhaka A , et al. 2002 The RAS effector RIN1 directly competes with RAF and is regulated by 14-3-3 proteins. Mol Cell Biol 22 916926. (https://doi.org/10.1128/MCB.22.3.916-926.2001)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Wang X , Cheng W , Li J , et al. 2015 Endocrine tumours: familial nonmedullary thyroid carcinoma is a more aggressive disease: a systematic review and meta-analysis. Eur J Endocrinol 172 R253R262. (https://doi.org/10.1530/EJE-14-0960)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Wang Y , Liyanarachchi S , Miller KE , et al. 2019 Identification of rare variants predisposing to thyroid cancer. Thyroid 29 946955. (https://doi.org/10.1089/THY.2018.0736)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Zhang W , Veisaga ML & Barbieri MA 2020 Role of RIN1 on telomerase activity driven by EGF-Ras mediated signaling in breast cancer. Exp Cell Res 396 112318. (https://doi.org/10.1016/J.YEXCR.2020.112318)

    • PubMed
    • Search Google Scholar
    • Export Citation